Your browser doesn't support javascript.
loading
Treatment of Philadelphia-negative myeloproliferative neoplasms in accelerated/blastic phase with azacytidine. Clinical results and identification of prognostic factors.
Andriani, Alessandro; Elli, Elena; Trapè, Giulio; Villivà, Nicoletta; Fianchi, Luana; Di Veroli, Ambra; Niscola, Pasquale; Centra, Antonia; Anaclerico, Barbara; Montanaro, Guido; Martini, Vincenza; Aroldi, Andrea; Carmosino, Ida; Voso, Maria Teresa; Breccia, Massimo; Montanaro, Marco; Foà, Roberto; Latagliata, Roberto.
Afiliação
  • Andriani A; Hematology, Fabrizio Spaziani Hospital, Frosinone, Italy.
  • Elli E; Hematology, San Gerardo Hospital, Monza, Italy.
  • Trapè G; Hematology, Belcolle Hospital, Viterbo, Italy.
  • Villivà N; UOSD of Hematology, ASL Roma 1, Rome, Italy.
  • Fianchi L; Hematology, Sacred Hearth Catholic University of Rome, Milan, Italy.
  • Di Veroli A; Hematology, University Tor Vergata, Rome, Italy.
  • Niscola P; Hematology, Sant'Eugenio Hospital, Rome, Italy.
  • Centra A; Hematology, Polo Universitario Pontino, Latina, Italy.
  • Anaclerico B; Hematology, San Giovanni Hospital, Rome, Italy.
  • Montanaro G; Department of Hematology, Santo Spirito Hospital, Pescara, Italy.
  • Martini V; Hematology, Fabrizio Spaziani Hospital, Frosinone, Italy.
  • Aroldi A; Hematology, San Gerardo Hospital, Monza, Italy.
  • Carmosino I; Hematology, Department of Translational and Precision Medicine, Policlinico Umberto I, Sapienza University, Rome, Italy.
  • Voso MT; Hematology, Sacred Hearth Catholic University of Rome, Milan, Italy.
  • Breccia M; Hematology, Department of Translational and Precision Medicine, Policlinico Umberto I, Sapienza University, Rome, Italy.
  • Montanaro M; Hematology, Belcolle Hospital, Viterbo, Italy.
  • Foà R; Hematology, Department of Translational and Precision Medicine, Policlinico Umberto I, Sapienza University, Rome, Italy.
  • Latagliata R; Hematology, Department of Translational and Precision Medicine, Policlinico Umberto I, Sapienza University, Rome, Italy.
Hematol Oncol ; 37(3): 291-295, 2019 Aug.
Article em En | MEDLINE | ID: mdl-31050810
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azacitidina / Crise Blástica / Transtornos Mieloproliferativos / Antimetabólitos Antineoplásicos Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Hematol Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azacitidina / Crise Blástica / Transtornos Mieloproliferativos / Antimetabólitos Antineoplásicos Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Hematol Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Itália